Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Esperion Therapeutics Inc | ESPR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.99 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.99 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.70 - 3.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.99 | USD |
Esperion Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 368.25M | 185.05M | - | 116.33M | -209.25M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Esperion Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ESPR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.78 | 2.16 | 1.71 | 2.01 | 5,515,336 | 0.21 | 11.80% |
| 1 Month | 2.70 | 3.40 | 1.71 | 2.55 | 7,676,784 | -0.71 | -26.30% |
| 3 Months | 2.09 | 3.40 | 1.71 | 2.51 | 6,379,320 | -0.10 | -4.78% |
| 6 Months | 0.78 | 3.40 | 0.706 | 2.25 | 6,019,012 | 1.21 | 155.13% |
| 1 Year | 1.22 | 3.40 | 0.70 | 1.93 | 4,590,209 | 0.77 | 63.11% |
| 3 Years | 27.59 | 28.75 | 0.70 | 3.82 | 2,644,734 | -25.60 | -92.79% |
| 5 Years | 43.86 | 79.989 | 0.70 | 8.73 | 1,829,417 | -41.87 | -95.46% |
Esperion Therapeutics Description
| Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. |
